A‐to‐I RNA Edited miR‐605‐3p Has a Heightened Anti‐Tumor Effect in Colorectal Cancer Through Modulating Immune Infiltration Mediated by CDK6
The A-to-I RNA edited miR-605-3p demonstrates a more potent anti-tumor effect in CRC by modulating CD8+ T cell immune infiltration mediated by CDK6. This study unveils edited miR-605-3p as a potential prognostic biomarker and highlights the ADAR2-miR-605-3p axis as a novel therapeutic target for CRC.
Authors
- Shuai Wang (ORCID: https://orcid.org/0000-0001-5670-1381)
- Danyang Li (ORCID: https://orcid.org/0000-0001-7470-6645)
- Xiujun Cai (ORCID: https://orcid.org/0000-0003-2514-1486)
- C Y Guo (ORCID: https://orcid.org/0009-0006-3225-9027)
- Kuang Gou
Institutions
- Xian Yang Central Hospital (CN)
Publication Details
- Journal
- The Journal of Gene Medicine
- Published
- 2025-11-26
- DOI
- https://doi.org/10.1002/jgm.70060
- Primary Topic
- RNA regulation and disease
- Type
- article
- Field-Weighted Citation Impact
- 0.00